Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
9.13
+0.04 (0.45%)
Mar 20, 2026, 12:31 PM EDT - Market open
Rallybio Market Cap
Rallybio has a market cap or net worth of $48.3 million as of March 20, 2026. Its market cap has increased by 67.27% in one year.
Market Cap
48.30M
Enterprise Value
-6.48M
1-Year Change
67.27%
Ranking
Category
Stock Price
$9.13
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $48.30M, a decrease of -88.09%. That is a compound annual growth rate of -36.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 48.08M | 65.90% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 54.97M |
| Metagenomi Therapeutics | 54.93M |
| NRx Pharmaceuticals | 54.79M |
| ImmuCell | 54.73M |
| OS Therapies | 53.88M |
| Acrivon Therapeutics | 52.38M |
| Decoy Therapeutics | 50.53M |
| GeoVax Labs | 50.50M |